The Journal of Immunology, Vol 138, Issue 3 720-725, Copyright © 1987 by American Association of Immunologists

ARTICLES

Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors

EA Clark and G Shu

Human B cells can be activated with monoclonal antibodies (mAb) to surface IgM receptors or mAb to a 35-kilodalton B cell differentiation antigen, Bp35 (CD20). We compared anti-Ig-induced B cell activation with B cell triggering by anti-Bp35. Both anti-Ig- and anti-Bp35- dependent proliferation were augmented by the same co-stimulants, including a partially purified BCGF, recombinant IL 1, TPA, or each other. When anti-Bp35 and anti-Ig were used together to induce proliferation of tonsillar B cells, the strongest response was observed when anti-Bp35 was added 12 to 24 hr before anti-Ig. Anti-Bp35 also was found to act most effectively when added before the BCGF. Blood and tonsillar B cells differed in their proliferative response to anti-Ig or anti-Bp35: unlike dense tonsillar B cells, which consistently proliferated in response to either stimulus, blood B cells from many donors proliferated in response to anti-Ig but not to anti-Bp35 even in the presence of other co-stimuli. Dense tonsillar B cells that proliferate in response to anti-Bp35 appeared to be at a more activated stage than unresponsive blood B cells because they expressed higher levels of HLA class II molecules than blood B cells. Pretreatment of blood B cells with anti-Bp35 converted them to an HLA-DR(bri) phenotype and made them more responsive to anti-Ig-induced proliferation. These results suggest that B cells at different stages of differentiation differ in their response to anti-Bp35 and anti-Ig. The Bp35 surface polypeptide may play an early role in the activation of B cells prior to antigen or other signals.

This article has been cited by other articles:

				J. Uchida, Y. Lee, M. Hasegawa, Y. Liang, A. Bradney, J. A. Oliver, K. Bowen, D. A. Steeber, K. M. Haas, J. C. Poe, et al. Mouse CD20 expression and function Int. Immunol., January 1, 2004; 16(1): 119 - 129. [Abstract] [Full Text] [PDF]

				M. J. Polyak and J. P. Deans Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure Blood, May 1, 2002; 99(9): 3256 - 3262. [Abstract] [Full Text] [PDF]

				J. Golay, L. Zaffaroni, T. Vaccari, M. Lazzari, G.-M. Borleri, S. Bernasconi, F. Tedesco, A. Rambaldi, and M. Introna Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis Blood, June 15, 2000; 95(12): 3900 - 3908. [Abstract] [Full Text] [PDF]

				M. J. Polyak, S. H. Tailor, and J. P. Deans Identification of a Cytoplasmic Region of CD20 Required for Its Redistribution to a Detergent-Insoluble Membrane Compartment J. Immunol., October 1, 1998; 161(7): 3242 - 3248. [Abstract] [Full Text] [PDF]

				J. P. Deans, S. M. Robbins, M. J. Polyak, and J. A. Savage Rapid Redistribution of CD20 to a Low Density Detergent-insoluble Membrane Compartment J. Biol. Chem., January 2, 1998; 273(1): 344 - 348. [Abstract] [Full Text] [PDF]

				J. P. Deans, L. Kalt, J. A. Ledbetter, G. L. Schieven, J. B. Bolen, and P. Johnson Association of 75/80-kDa Phosphoproteins and the Tyrosine Kinases Lyn, Fyn, and Lck with the B Cell Molecule CD20 J. Biol. Chem., September 22, 1995; 270(38): 22632 - 22638. [Abstract] [Full Text] [PDF]